U.S., March 1 -- ClinicalTrials.gov registry received information related to the study (NCT06852911) titled 'FeNO Detection in Asthma Diagnosis: A New Technology Approach' on Feb. 14.
Brief Summary: The detection of exhaled nitric oxide (FeNO) represents a non-invasive, safe, and rapid approach for assessing endogenous nitric oxide (NO) levels within the airway. FeNO concentrations are closely associated with airway inflammation and hyperresponsiveness, and are currently recognized as biomarkers indicative of type II airway inflammation. Recent advancements in nitric oxide detection technology for both upper and lower airways, as well as for small and large airways, have provided significant insights for the diagnosis and management of con...